Literature DB >> 7010641

Cancer of the ampulla of vater, bile duct, and duodenum.

A M Cooperman.   

Abstract

The presenting features of periampullary cancer have been reviewed. Unless the neoplasm is discovered as an incidental finding at surgery, diagnosis is not made until the onset of symptoms (pain, jaundice, weight loss), which is not early, even though these tumors are close to the bile duct or ampulla of Vater. Individual philosophies aside, the prognosis for ampullary, duodenal, or distal bile duct tumors reflects the grade and stage of tumor as much as the operation done. Pancreatoduodenal resection, standard or modified, should be done with an attempt to cure and not to palliate. Statistics that show superior results after resection compared with palliative procedures reflect earlier stages lesions, healthier patients, and, most importantly, patient selection.

Entities:  

Mesh:

Year:  1981        PMID: 7010641     DOI: 10.1016/s0039-6109(16)42335-2

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  4 in total

1.  [Prognostically relevant factors in cancer of Vater's ampulla].

Authors:  T Böttger; J Zech; W Weber; K Sorger; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1989

2.  Tumours and pseudotumours of the region of the ampulla of Vater: an endoscopic, clinical and pathological study.

Authors:  T Leese; J P Neoptolemos; K P West; I C Talbot; D L Carr-Locke
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

3.  Digestive and nutritional consequences of pancreatic resections. The classical vs the pylorus-sparing procedure.

Authors:  F Crucitti; G Doglietto; R Bellantone; G A Miggiano; D Frontera; A M Ferrante; A Castelli
Journal:  Int J Pancreatol       Date:  1995-02

4.  Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.

Authors:  Calogero Iacono; Giuseppe Verlato; Giuseppe Zamboni; Aldo Scarpa; Ettore Montresor; Paola Capelli; Luca Bortolasi; Giovanni Serio
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.